Deinove (ALDEI)

Business description

Deinove is a biotech company that discovers, develops and manufactures compounds of industrial interest stemming from rare bacteria and intended for the health, nutrition and beauty markets.

Milestone payments demonstrate progress

Update | Alternative Energy | 25/09/2015

Deinove continues to make progress, passing research project milestones, signing agreements with commercial partners and diversifying future potential revenue streams by broadening its research platform. The company has yet to generate commercial revenue (we expect from FY17), but believes it has sufficient cash resources to last “beyond Q316”.

Edison's research is freely available. We will never ask for your credit card details and you do not need to register. By downloading this research you are agreeing to our terms and conditions, which you can read in full here.

Stock data

Market cap.€44.7m
Last close€3.780
High / Low (52 weeks)€4.4 / €1.6
Stock market listingEG
Forecast net debt (€m)5.1
Forecast gearing ratio (%)
TeamIndustrials
SectorAlternative Energy

Price performance

%1m3m12m
Actual(2.1)96.986.2
Relative *(7.7)100.772.1

* % Relative to local index

Company news